Expression of GNAS in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

GNAS is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2039.28

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

2476.7

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	9265.6
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	6562.1
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	5510.4
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	5492.2
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	5382.7
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	5011.8
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	4793.3
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	4721.4
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	4667.8
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	4566.4
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	4356.3
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	4351.4
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	4208.0
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	4035.5
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	4004.4
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	3868.9
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	3755.5
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	3607.0
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	3592.6
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	3470.8
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	3453.4
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	3347.3
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	3257.8
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	3152.0
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	3135.9
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	3132.7
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	3113.3
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	3108.3
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	3098.0
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	3084.8
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	3045.6
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	3005.0
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	2983.2
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	2927.2
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	2906.7
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	2878.8
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	2835.9
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	2818.0
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	2812.6
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	2795.9
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	2708.8
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	2646.1
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	2609.7
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	2601.4
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	2596.2
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	2588.7
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	2587.6
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	2563.6
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	2530.7
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	2525.1
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	2518.5
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	2507.9
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	2481.4
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	2481.0
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	2454.1
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	2426.6
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	2412.0
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	2382.9
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	2374.0
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	2370.7
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	2358.4
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	2353.1
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	2288.7
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	2277.5
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	2261.9
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	2249.1
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	2247.4
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	2233.1
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	2226.9
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	2201.2
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	2179.3
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	2179.3
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	2173.3
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	2139.2
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	2137.9
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	2136.0
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	2132.7
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	2114.3
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	2086.5
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	2079.5
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	2072.3
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	2060.7
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	2058.2
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	2048.6
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	2047.6
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	2039.3
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1975.9
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1970.3
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	1929.0
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1897.0
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	1894.0
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1889.0
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	1874.6
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1837.3
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	1822.1
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1815.3
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	1811.9
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	1811.6
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	1809.8
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	1799.5
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	1796.8
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1788.7
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	1787.7
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1780.1
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1778.9
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	1751.5
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1745.0
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	1738.7
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	1726.2
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	1723.5
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	1716.7
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	1689.5
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	1679.6
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	1676.3
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	1663.9
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	1661.2
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	1655.9
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	1647.0
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1645.1
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	1614.2
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	1602.2
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1581.4
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	1580.8
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	1510.6
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	1484.7
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	1472.5
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	1457.6
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1432.3
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	1390.4
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1298.9
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	1273.7
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	1262.4
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	1209.7
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	1200.5
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	1133.0
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	1056.9
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	1010.0
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	886.8
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	793.1
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	684.8
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	629.1
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

GNAS is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 218.59

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

305.5

Number of samples

Samples

Sample	Description	pTPM
AK088	N, NA, stage:NA, dead, 360 days	811.5
AK142	N, NA, stage:NA, alive, 90 days	702.6
AK158	N, NA, stage:NA, dead, 360 days	558.9
AK123	N, NA, stage:NA, dead, 180 days	555.3
AK035	N, NA, stage:NA, dead, 210 days	522.3
AK226	N, NA, stage:NA, dead, 360 days	507.1
AK002	N, NA, stage:NA, dead, 570 days	460.0
AK100	N, NA, stage:NA, alive, 960 days	431.7
AK074	N, NA, stage:NA, alive, 300 days	423.4
AK099	N, NA, stage:NA, dead, 420 days	420.5
AK076	N, NA, stage:NA, alive, 660 days	408.6
AK081	N, NA, stage:NA, dead, 180 days	402.4
AK066	N, NA, stage:NA, alive, 960 days	373.9
AK043	N, NA, stage:NA, alive, 660 days	372.5
AK053	N, NA, stage:NA, dead, 300 days	366.6
AK117	N, NA, stage:NA, dead, 210 days	341.9
AK133	N, NA, stage:NA, dead, 360 days	339.0
AK199	N, NA, stage:NA, alive, 1860 days	325.6
AK134	N, NA, stage:NA, dead, 360 days	325.3
AK124	N, NA, stage:NA, alive, 1920 days	324.3
AK173	N, NA, stage:NA, dead, 180 days	309.7
AK085	N, NA, stage:NA, alive, 660 days	298.6
AK089	N, NA, stage:NA, dead, 330 days	294.6
AK178	N, NA, stage:NA, dead, 240 days	290.8
AK079	N, NA, stage:NA, dead, 210 days	278.5
AK015	N, NA, stage:NA, alive, 720 days	275.3
AK218	N, NA, stage:NA, dead, 180 days	268.4
AK167	N, NA, stage:NA, dead, 180 days	266.6
AK149	N, NA, stage:NA, dead, 420 days	258.9
AK231	N, NA, stage:NA, dead, 240 days	253.5
AK165	N, NA, stage:NA, alive, 360 days	252.9
AK071	N, NA, stage:NA, dead, 540 days	252.4
AK183	N, NA, stage:NA, alive, 360 days	250.6
AK030	N, NA, stage:NA, dead, 120 days	248.0
AK068	N, NA, stage:NA, alive, 360 days	243.7
AK051	N, NA, stage:NA, dead, 360 days	240.6
AK003	N, NA, stage:NA, dead, 600 days	239.2
AK098	N, NA, stage:NA, dead, 660 days	235.5
AK213	N, NA, stage:NA, alive, 2010 days	232.4
AK103	N, NA, stage:NA, alive, 1320 days	230.1
AK072	N, NA, stage:NA, dead, 150 days	227.0
AK091	N, NA, stage:NA, dead, 210 days	222.8
AK041	N, NA, stage:NA, alive, 810 days	220.5
AK102	N, NA, stage:NA, alive, 1740 days	219.2
AK195	N, NA, stage:NA, dead, 390 days	218.0
AK139	N, NA, stage:NA, dead, 270 days	214.3
AK188	N, NA, stage:NA, alive, 420 days	208.5
AK185	N, NA, stage:NA, alive, 330 days	206.6
AK227	N, NA, stage:NA, alive, 300 days	205.0
AK205	N, NA, stage:NA, dead, 120 days	192.8
AK153	N, NA, stage:NA, dead, 240 days	190.2
AK236	N, NA, stage:NA, dead, 360 days	186.1
AK006	N, NA, stage:NA, dead, 360 days	177.9
AK216	N, NA, stage:NA, dead, 360 days	173.4
AK055	N, NA, stage:NA, dead, 240 days	171.3
AK156	N, NA, stage:NA, dead, 330 days	167.0
AK005	N, NA, stage:NA, dead, 240 days	166.3
AK049	N, NA, stage:NA, dead, 180 days	158.9
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0218890004	Tumor	0.9
CPT0206780003	Tumor	0.7
CPT0093450003	Tumor	0.7
CPT0162140003	Tumor	0.7
CPT0204370003	Normal	0.7
CPT0221180003	Tumor	0.7
CPT0204350003	Normal	0.6
CPT0206880003	Tumor	0.6
CPT0204380003	Normal	0.6
CPT0204410003	Normal	0.5
CPT0204360003	Normal	0.5
CPT0218690004	Tumor	0.5
CPT0204400003	Normal	0.5
CPT0087570003	Tumor	0.4
CPT0205890003	Tumor	0.4
CPT0204330003	Normal	0.4
CPT0190240004	Tumor	0.4
CPT0189850004	Tumor	0.4
CPT0204390003	Normal	0.4
CPT0205780003	Tumor	0.4
CPT0175060003	Tumor	0.3
CPT0204420003	Normal	0.3
CPT0204340003	Normal	0.2
CPT0189250003	Tumor	0.2
CPT0218670003	Tumor	0.2
CPT0201710003	Tumor	0.2
CPT0224330003	Tumor	0.2
CPT0093590003	Tumor	0.2
CPT0217190003	Tumor	0.2
CPT0225730003	Tumor	0.2
CPT0087950003	Tumor	0.2
CPT0078580003	Tumor	0.2
CPT0206330003	Tumor	0.1
CPT0123530003	Tumor	0.1
CPT0104220003	Tumor	0.1
CPT0190360004	Tumor	0.1
CPT0199770003	Tumor	0.0
CPT0125220003	Tumor	0.0
CPT0002410011	Tumor	0.0
CPT0168270003	Tumor	0.0
CPT0104330003	Tumor	0.0
CPT0087730003	Tumor	0.0
CPT0189750004	Tumor	0.0
CPT0125510003	Tumor	-0.1
CPT0064890003	Tumor	-0.1
CPT0182500003	Tumor	-0.1
CPT0189460003	Tumor	-0.1
CPT0167530003	Tumor	-0.1
CPT0093510003	Tumor	-0.1
CPT0225760003	Tumor	-0.1
CPT0218770003	Tumor	-0.1
CPT0217100003	Tumor	-0.1
CPT0209440003	Tumor	-0.1
CPT0219080004	Tumor	-0.1
CPT0186100003	Tumor	-0.1
CPT0093360003	Tumor	-0.2
CPT0217060003	Tumor	-0.2
CPT0167750004	Tumor	-0.2
CPT0207030003	Tumor	-0.2
CPT0127480003	Tumor	-0.2
CPT0189650004	Tumor	-0.2
CPT0161730003	Tumor	-0.2
CPT0071100003	Tumor	-0.2
CPT0206110003	Tumor	-0.2
CPT0205670004	Tumor	-0.2
CPT0092440003	Tumor	-0.2
CPT0089150003	Tumor	-0.2
CPT0217880003	Tumor	-0.2
CPT0206450003	Tumor	-0.3
CPT0127420003	Tumor	-0.3
CPT0162100003	Tumor	-0.3
CPT0167640003	Tumor	-0.3
CPT0208980003	Tumor	-0.3
CPT0196850003	Tumor	-0.3
CPT0218960004	Tumor	-0.3
CPT0224390004	Tumor	-0.3
CPT0205570003	Tumor	-0.3
CPT0167970003	Tumor	-0.3
CPT0217000004	Tumor	-0.3
CPT0064650003	Tumor	-0.3
CPT0182550003	Tumor	-0.3
CPT0168380003	Tumor	-0.3
CPT0171580008	Tumor	-0.4
CPT0206670004	Tumor	-0.4
CPT0189570004	Tumor	-0.4
CPT0167860004	Tumor	-0.4
CPT0217710008	Tumor	-0.4
CPT0168830003	Tumor	-0.4
CPT0182580003	Tumor	-0.4
CPT0218830004	Tumor	-0.4
CPT0125570003	Tumor	-0.4
CPT0205450004	Tumor	-0.4
CPT0087680003	Tumor	-0.5
CPT0224600003	Tumor	-0.5
CPT0079790003	Tumor	-0.5
CPT0206000004	Tumor	-0.5
CPT0093550003	Tumor	-0.5
CPT0168480003	Tumor	-0.5
CPT0216920008	Tumor	-0.5
CPT0168720003	Tumor	-0.6
CPT0168590003	Tumor	-0.6
CPT0168080003	Tumor	-0.6
CPT0224540004	Tumor	-0.6
CPT0218330004	Tumor	-0.6
CPT0217430008	Tumor	-0.7
CPT0162020003	Tumor	-0.7
CPT0228220003	Tumor	-0.7
CPT0206230003	Tumor	-0.8
CPT0207090003	Tumor	-0.9
CPT0206560003	Tumor	-1.3
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA018122	Antibody HPA027478	Antibody HPA028386	Antibody CAB010337
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade
Glioma, malignant, High grade Glioblastoma, NOS